Department of Surgery, Shanghai Institute of Digestive Surgery, Shanghai Ruijin Hospital, Shanghai Key Laboratory for Gastric Neoplasms, Shanghai Jiao Tong University, School of Medicine, Ruijin er Road, No. 197, 200025 Shanghai, China.
Gene. 2013 Sep 15;527(1):102-8. doi: 10.1016/j.gene.2013.05.034. Epub 2013 Jun 12.
HIC1 is a tumor suppressor gene that is down-expressed in different malignancies, in part, because of promoter hypermethylation. However, the biological function of HIC1 in gastric cancer remains unclear. It is known that small double-stranded RNAs can induce gene expression by targeting promoter sequences. In the present study, we examined the expression levels of HIC1 in gastric cancer tissue. Several pieces of small double-stranded RNAs were used for the activation of HIC1. Tissue microarray analysis of gastric cancer indicated that down-regulation of HIC1 in gastric cancer tissue was dramatic compared with the adjacent gastric mucosa. Gastric cancer cell lines also showed down-regulated HIC1 expression compared with a human immortalized gastric mucosa cell line. One out of four dsRNAs produced activation of HIC1 as assessed by real-time PCR and Western blotting. Use of a cell counting kit 8 and clonogenicity assays indicated that dsRNA-mediated re-expression of HIC1 inhibited cell proliferation and clonogenicity in gastric cancer. Reactivation of HIC1 suppressed cell migration and induced cell cycle arrest in the G0/G1 phase, as well as induced apoptosis. These results suggest that HIC1 is a potential target of gene therapy against gastric cancer, and that dsRNAs could function as a therapeutic option for up-regulating tumor suppressor genes in gastric cancer and other malignancies.
HIC1 是一种肿瘤抑制基因,在不同的恶性肿瘤中表达下调,部分原因是启动子过度甲基化。然而,HIC1 在胃癌中的生物学功能尚不清楚。已知小双链 RNA 可以通过靶向启动子序列来诱导基因表达。在本研究中,我们检测了胃癌组织中 HIC1 的表达水平。使用几种小双链 RNA 来激活 HIC1。胃癌组织的组织微阵列分析表明,与相邻的胃黏膜相比,胃癌组织中 HIC1 的下调非常明显。与人类永生化胃黏膜细胞系相比,胃癌细胞系也显示出 HIC1 表达下调。实时 PCR 和 Western blot 评估显示,有 1/4 的 dsRNA 产生了 HIC1 的激活。使用细胞计数试剂盒 8 和集落形成测定表明,dsRNA 介导的 HIC1 重新表达抑制了胃癌细胞的增殖和集落形成。HIC1 的重新激活抑制了细胞迁移,并诱导细胞周期停滞在 G0/G1 期,同时诱导细胞凋亡。这些结果表明,HIC1 是胃癌基因治疗的潜在靶点,dsRNA 可作为上调胃癌和其他恶性肿瘤中肿瘤抑制基因的治疗选择。